Editors' ChoiceCancer and Immunology

Dynamic Duo: Cancer Drugs and the Immune System

See allHide authors and affiliations

Science Translational Medicine  23 Dec 2009:
Vol. 1, Issue 12, pp. 12ec44
DOI: 10.1126/scitranslmed.3000733

You are currently viewing the summary.

View Full Text

Summary

In mice with ovarian cancer, treatment with both the drug Doxil and the cytokine interleukin-18 inhibits tumor growth and promotes tumor regression better than either therapy alone.